Demand for transplant diagnostic products is expected to increase, mainly due to factors such as increased public-private partnership funding for targeted research activities, increased burden of infectious diseases, increased number of transplant procedures, and technological advancements in the field of transplant diagnostics. The market segment by technology is divided into molecular and non-molecular analytical technologies. The field of molecular analysis technology has the largest market share. A large part of this part can be attributed to the benefits of molecular detection, such as short turnaround time, high program efficiency, research on multiple samples, and real-time sample analysis.

Market Analysis and Insights: Global Organ Transplant Diagnostics Market
The global Organ Transplant Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Organ Transplant Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Organ Transplant Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Organ Transplant Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Organ Transplant Diagnostics market.

Global Organ Transplant Diagnostics Scope and Market Size
Organ Transplant Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Organ Transplant Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Molecular Assay Technologies
Non-molecular Assay Technologies

Segment by Application
Independent Reference Laboratories
Hospitals and Transplant Centers
Research Laboratories and Academic Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
QIAGEN NV
Thermo Fisher Scientific
BioMérieuxSA
CareDx
Luminex Corporation
Dickinson and Company
Biofortuna